Delivery Order SPE2DB20D1109-SPE2DB23FN60V

Award Date 2/23/23
Potential Completion Date 2/24/23
Potential Value $22K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Januvia 100 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $5,026.83, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, with a total potential value of $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle...
The federal contract award is for the delivery of Januvia 50 mg tablets to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract, which is a firm fixed-price delivery order valued at $17,836.86, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a period of performance through July 23, 2024. Amerisourcebergen is a large supplier of pharmaceutical products and medical supplies to the U.S. government, including...
This federal contract award is for the delivery of Januvia 100 mg tablets in quantities of 1,000 to the Defense Logistics Agency (DLA). The contract, valued at $15,213.42, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of September 1, 2023 and is a firm fixed-price delivery order. There is no set-aside designation mentioned in the information provided. Amerisourcebergen Drug Corp is...
This federal contract award is for the delivery of JANUVIA 100 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $6,948 contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 6, 2024. The contract has a firm fixed price and is set to expire on September 9, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves...
This federal contract award is for the delivery of JANUVIA 100 MG TABLET 90S to the Defense Logistics Agency (DLA), a defense agency. The $2,392.40 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a period of performance through November 25, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award is for the delivery of JANUVIA 100 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $11,021.94 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of July 10, 2023 and was awarded on July 7, 2023. There is no set-aside designation for this contract. Amerisourcebergen Drug Corp holds a $999,999,999...
This federal contract award is for the delivery of JANUVIA 100 MG TABLET 90S, valued at $10,862.22, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a firm fixed-price delivery order contract with an ultimate completion date of January 3, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of JANUVIA 100 MG TABLET 1000S to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $6,048.70, has an ultimate completion date of March 26, 2025. The contract is not set aside for any specific business type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
The federal contract award is for the delivery of JANUVIA 100 MG TABLET 1000S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,440.39 and is a Firm Fixed Price Delivery Order, with a completion date of December 14, 2023. The contract is not designated as a set-aside....
This federal contract award is for the delivery of Januvia 100 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $11,528.06, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order with a firm fixed price, with a completion date of September 19, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB23FN60V
    Delivery Order

This federal contract award is for the delivery of JANUVIA 100 MG TABLET 90S to the Defense Logistics Agency (DLA), with a ceiling value of $22,444.99. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract does not have a set-aside designation, indicating open competition.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 12:02 PM